Literature DB >> 17204482

Convergence of p53 and transforming growth factor beta (TGFbeta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells.

Shizhen Emily Wang1, Archana Narasanna, Corbin W Whitell, Frederick Y Wu, David B Friedman, Carlos L Arteaga.   

Abstract

Using two-dimensional difference gel electrophoresis, we identified the tumor suppressor gene maspin as a transforming growth factor beta (TGFbeta) target gene in human mammary epithelial cells. TGFbeta up-regulatesMaspin expression both at the RNA and protein levels. This up-regulation required Smad2/3 function and intact p53-binding elements in the Maspin promoter. DNA affinity immunoblot and chromatin immunoprecipitation revealed the presence of both Smads and p53 at the Maspin promoter in TGFbeta-treated cells, suggesting that both transcription factors cooperate to induce Maspin transcription. TGFbeta did not activate Maspin-luciferase reporter in p53-mutant MDA-MB-231 breast cancer cells, which exhibit methylation of the endogenous Maspin promoter. Expression of ectopic p53, however, restored ligand-induced association of Smad2/3 with a transfected Maspin promoter. Stable transfection of Maspin inhibited basal and TGFbeta-stimulated MDA-MB-231 cell motility. Finally, knockdown of endogenous Maspin in p53 wild-type MCF10A/HER2 cells enhanced basal and TGFbeta-stimulated motility. Taken together, these data support cooperation between the p53 and TGFbeta tumor suppressor pathways in the induction of Maspin expression, thus leading to inhibition of cell migration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204482      PMCID: PMC4015524          DOI: 10.1074/jbc.M608499200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

2.  A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene.

Authors:  Deepti S Wilkinson; Stacey K Ogden; Sabrina A Stratton; Julie L Piechan; Thi T Nguyen; George A Smulian; Michelle Craig Barton
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

3.  Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Incheol Shin; Shimian Qu; Carlos L Arteaga
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

5.  Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.

Authors:  Valerie A Odero-Marah; Zhila Khalkhali-Ellis; Jirapat Chunthapong; Sumaira Amir; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

6.  Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer.

Authors:  J A Foekens; F Buessecker; H A Peters; U Krainick; W L van Putten; M P Look; J G Klijn; M D Kramer
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

7.  Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions.

Authors:  Shirley L Smith; Suzanne G Watson; Daniel Ratschiller; Mathias Gugger; Daniel C Betticher; Jim Heighway
Journal:  Oncogene       Date:  2003-11-27       Impact factor: 9.867

8.  Staphylococcus aureus redirects central metabolism to increase iron availability.

Authors:  David B Friedman; Devin L Stauff; Gleb Pishchany; Corbin W Whitwell; Victor J Torres; Eric P Skaar
Journal:  PLoS Pathog       Date:  2006-08       Impact factor: 6.823

Review 9.  Convergence of p53 and TGF-beta signaling networks.

Authors:  Sirio Dupont; Luca Zacchigna; Maddalena Adorno; Sandra Soligo; Dino Volpin; Stefano Piccolo; Michelangelo Cordenonsi
Journal:  Cancer Lett       Date:  2004-09-30       Impact factor: 8.679

10.  p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.

Authors:  Andrei V Bakin; Cammie Rinehart; Anne K Tomlinson; Carlos L Arteaga
Journal:  J Cell Sci       Date:  2002-08-01       Impact factor: 5.285

View more
  18 in total

1.  CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

Authors:  Akihiro Tsuyada; Amy Chow; Jun Wu; George Somlo; Peiguo Chu; Sofia Loera; Thehang Luu; Arthur Xuejun Li; Xiwei Wu; Wei Ye; Shiuan Chen; Weiying Zhou; Yang Yu; Yuan-Zhong Wang; Xiubao Ren; Hui Li; Peggy Scherle; Yukio Kuroki; Shizhen Emily Wang
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

2.  Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells.

Authors:  Yang Yu; Yujun Wang; Xiubao Ren; Akihiro Tsuyada; Arthur Li; Liguang James Liu; Shizhen Emily Wang
Journal:  Mol Cancer Res       Date:  2010-10-14       Impact factor: 5.852

3.  Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing.

Authors:  Manasa Chandra; Shengbing Zang; Haiqing Li; Lisa J Zimmerman; Jackson Champer; Akihiro Tsuyada; Amy Chow; Weiying Zhou; Yang Yu; Harry Gao; Xiubao Ren; Ren-Jang Lin; Shizhen Emily Wang
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

4.  Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.

Authors:  M Margarida Bernardo; Yonghong Meng; Jaron Lockett; Gregory Dyson; Alan Dombkowski; Alexander Kaplun; Xiaohua Li; Shuping Yin; Sijana Dzinic; Mary Olive; Ivory Dean; David Krass; Kamiar Moin; R Daniel Bonfil; Michael Cher; Wael Sakr; Shijie Sheng
Journal:  Genes Cancer       Date:  2011-11

5.  Identification of phosphorylation sites on extracellular corneal epithelial cell maspin.

Authors:  Malathi Narayan; Shama P Mirza; Sally S Twining
Journal:  Proteomics       Date:  2011-03-01       Impact factor: 3.984

6.  2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells.

Authors:  J Tyson DeAngelis; Yuanyuan Li; Natalie Mitchell; Landon Wilson; Helen Kim; Trygve O Tollefsbol
Journal:  J Proteome Res       Date:  2010-12-20       Impact factor: 4.466

Review 7.  When tumor suppressor TGFβ meets the HER2 (ERBB2) oncogene.

Authors:  Amy Chow; Carlos L Arteaga; Shizhen Emily Wang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-06       Impact factor: 2.673

8.  The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.

Authors:  Yari Ciribilli; Virginia Andreotti; Daniel Menendez; Jan-Stephan Langen; Gilbert Schoenfelder; Michael A Resnick; Alberto Inga
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

9.  Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes.

Authors:  David H Nguyen; Erik Fredlund; Wei Zhao; Charles M Perou; Allan Balmain; Jian-Hua Mao; Mary Helen Barcellos-Hoff
Journal:  Clin Cancer Res       Date:  2013-01-21       Impact factor: 12.531

10.  TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes.

Authors:  Liang Liu; Weiying Zhou; Chun-Ting Cheng; Xiubao Ren; George Somlo; Miranda Y Fong; Andrew R Chin; Hui Li; Yang Yu; Yang Xu; Sean Timothy Francis O'Connor; Timothy R O'Connor; David K Ann; Jeremy M Stark; Shizhen Emily Wang
Journal:  Mol Cancer Res       Date:  2014-08-07       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.